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Abstract We previously demonstrated that, in hepatocytes in 
primary culture, the role of insulin on induction of L-type 
pyruvate kinase (L-PK) gene expression was mainly to induce 
glucokinase synthesis, needed for glucose phosphorylation to 
glucose 6-phosphate. However, we show here that when 
hepatocytes have been isolated from rats starved for 72 h, 
glucose and constitutive glucokinase expression was not suffi-
cient to fully stimulate the L-PK promoter, low insulin 
concentrations being still required. In addition, activation 
remains sensitive to cAMP inhibition, but cannot be reproduced 
in the absence of insulin by a competitive cAMP antagonist. We 
propose that both insulin and cAMP act on expression of the L-
PK gene at, at least, two levels: positive and negative regulation 
of glucokinase gene expression, and more downstream levels. 
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1. Introduction 
Expression of the L-type pyruvate kinase (L-PK) gene, en-
coding a key enzyme of the glycolytic pathway, is transcrip-
tionally regulated, positively by glucose and insulin and neg-
atively by glucagon and cAMP. Previous studies have 
demonstrated that this transcriptional regulation by glucose 
and hormones could be ascribed to a 42 bp glucose response 
element (GIRE) [1-5]. We have previously shown that insulin 
can be replaced by constitutive glucokinase synthesis in hep-
atocytes in primary culture [6], and that glucose induction of 
the L-PK gene was independent of insulin in hepatoma cells 
synthesizing insulin-independent hexokinase isoforms instead 
of glucokinase [7]. These results suggested that activation of 
glucokinase gene expression, needed to phosphorylate glucose 
to glucose 6-phosphate, could be the only role of insulin in the 
transcriptional response of liver genes to glucose. This hy-
pothesis was strengthened and generalized by the recent re-
sults of Ferre et al., showing that expression of a glucokinase 
transgene, controlled by regulatory sequences of the phos-
phoenolpyruvate carboxykinase gene, normalized glucose me-
tabolism and gene expression in the liver of diabetic mice [8]. 
However, we show here that, in addition to its role in activa-
tion of the glucokinase gene, insulin at very low concentration 
could also be required for the L-PK gene to switch over from 
prolonged transcriptional inhibition to transcriptional activa-
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tion by glucose. This insulin effect is blocked by cAMP but 
cannot be mimicked by a cAMP antagonist. 
2. Materials and methods 
2.1. Construction of plasmids 
All plasmid constructions used have been previously described. The 
(L4L3)—119 PK/CAT construct comprises one copy of the L4L3 frag-
ment, liga ted to the 119 proximal base pairs of the L-PK promoter, 
which include the HNF1 and NF1 binding sites. The -150 PK/CAT 
construct comprises the HNF1, NF1 and HNF4 binding sites, but is 
devoid of the L4 element [1]. The glucokinase expression vector is 
made of a 2.3 kbp fragment of glucokinase cDNA [9], containing 
the entire coding region, inserted between the CMV promoter and 
the SV40 polyadenylation signal [7]. As a control expression vector, 
we used an empty PGEM1 vector, including the CMV promoter and 
the SV40 polyadenylation signal but devoid of glucokinase cDNA 
insertion. Accumulation of glucokinase mRNA 24 and 48 h after 
transfection of the glucokinase expression vector was shown by 
Northern blot analysis [6]. The protein kinase A (PKA) catalytic 
subunit expression vectors were a generous gift of R.A. Maurer. These 
plasmids contain the complete coding sequences of the a, ß or ß-
mutant catalytic subunits of Chinese hamster PKA, under the control 
of the RSV promoter, and have been extensively characterized else-
where [10]. 
2.2. Hepatocyte isolation, transfection, and cell culture conditions 
Male Sprague-Dawley rats (180-200 g) starved for 72 h were used 
in all experiments. Hepatocytes were obtained by the collagenase per-
fusion method as previously described [11]. 3 million freshly isolated 
cells were plated in 6 cm dishes, in 3 ml of 199 medium supplemented 
with 1 |iM iodothyronine, 1 u.M dexamethasone, and 10% (v/v) dia-
lysed fetal calf serum, replaced 6 h later by 199 medium plus hor-
mones and 3% dialysed fetal calf serum. 24 h after isolation, trans-
fection was performed by the lipofection method, using the DOTAP 
transfection reagent (Boehringer Mannheim), in 199 medium supple-
mented with 1 uM iodothyronine and 1 u.M dexamethasone. Hepato-
cytes were transfected as previously described [6], with either 5 ug of 
the KSV2CAT plasmid or the (L4L3)-119 PK/CAT plasmid, and 
either 20 ng of the glucokinase expression vector or the indicated 
amount of the expression vector for PKA catalytic subunits. Cells 
were then cultured in 199 medium containing tri-iodothyronine, dex-
amethasone, 5 mM or 25 mM glucose, and different concentrations of 
either insulin, 8-bromo-cAMP (Sigma), or (Rp)-cAMP(s) (Biolog) for 
approximately 40 h. Medium was replaced every 24 h. 
2.3. CAT assays 
Cellular protein extraction and CAT assays were performed as pre-
viously described [4]. CAT activity was determined with a Molecular 
Dynamics Phosphorimager. Results were standardized with respect to 
the amount of cellular proteins used in the CAT assay, then expressed 
as a percentage of the KSV2CAT activity measured in the same ex-
periment. 
2.4. Northern blot analysis 
Total RNA isolation and Northern blots experiments were per-
formed as previously described [2], Northern blots were hybridized 
with a 2600 bp rat PEPCK cDNA fragment as a probe [12]. A 
cDNA fragment encoding a ribosomal protein was used as a stand-
ardization probe [13]. Specific bands were quantified by scanning the 
autoradiographs on a Shimadzu densitometer. 
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Fig. 1. A: Dose-response curve of insulin effect on the (L4L3)—119 PK/CAT construct cotransfected with the glucokinase expression vector. 
The (L4L3)—119 PK/CAT reporter was transfected alone (black bars), or cotransfected with the glucokinase expression vector (gray bars), or 
the control expression vector (open bars). Hepatocytes were cultured in the presence of 25 mM glucose and various insulin concentrations. The 
CAT activity is expressed as a percentage of the control plasmid KSV2CAT activity. Each value is the mean of three to six experiments; verti-
cal bars indicate S.E.M. B: Effect of the glucokinase expression vector cotransfection on the —150 PK/CAT and KSV2CAT plasmid expres-
sion. In this typical experiment, (L4L3)—119 PK/CAT, —150 PK/CAT and KSV2CAT plasmids were either transfected alone, or cotransfected 
with the glucokinase expression vector or the control expression vector. Hepatocytes were then cultured in the presence of 25 mM glucose and 
0.2 nM insulin. Chloramphenicol 3-acetylated forms are indicated by arrows. 
3. Results and discussion 
3.1. Low insulin concentrations are required for activation of 
the L-PK promoter by glucose and glucokinase in culture 
of hepatocytes from starved rats 
We examined the effect of constitutive expression of gluco-
kinase on activity of the L-PK promoter in starved rat hep-
atocytes in primary cultures. Fig. 1A presents the activity 
generated by the (L4L3)—119 PK/CAT reporter construct in 
hepatocytes cultured in 25 mM glucose and at various insulin 
concentrations. When transfected alone, the activity of the 
reporter plasmid increased as a function of insulin concentra-
tion added to the medium, as expected [11]. Cotransfection 
with a glucokinase expression vector resulted in a poor stim-
ulation of the activity of the (L4L3)-119 PK/CAT construct 
in the absence of insulin. However, an insulin concentration 
as low as 0.2 nM led to a substantial activation of the 
(L4L3)—119 PK/CAT construct in hepatocytes cotransfected 
with the glucokinase expression vector. As exemplified in Fig. 
1A, neither expression of the —150 PK/CAT construct, devoid 
of the GIRE, nor expression of the KSV2CAT construct was 
modified by cotransfection with the glucokinase expression 
vector at the same insulin concentration. These negative re-
sults were confirmed by Phosphorimager assays. These con-
trols confirm that activation of the (L4L3)-119PK/CAT plas-
mid by glucose, insulin and constitutive glucokinase synthesis 
was dependent on the L-PK GIRE. 
The increase of L-PK promoter activity associated with 
glucokinase overexpression was about 3-fold, practically con-
stant between 2 and 20 nM insulin, conditions under which 
the endogenous glucokinase gene is transcribed and glucoki-
nase activity is present [14]. This indicates that the amount of 
active glucokinase is indeed a limiting factor for L-PK gene 
expression in hepatocytes in primary cultures, since the con-
tribution of exogenous glucokinase is able to further activate 
the L-PK promoter. Actually, measurement of glucokinase 
activity in hepatocytes in primary cultures demonstrated 
that it gradually decreases in the hours following isolation, 
to a steady-state level of approximately 10% of the initial 
activity, despite the presence of a very high insulin concentra-
tion (1 uM) in the culture medium [15]. Such a limiting role 
for glucokinase in transcriptional activation of the L-PK gene 
reinforces the idea that glucokinase plays a permissive role in 
gene activation by glucose [6]. However, glucokinase induc-
tion appears not to be the only role of insulin in activation of 
these genes, because very low concentrations of insulin remain 
required for activation of the L-PK promoter in hepatocytes 
isolated from starved rats and transfected with a glucokinase 
expression vector. These results are in contrast with those we 
previously reported in hepatocytes from fed rats, in which 
glucokinase expression was sufficient to allow for glucose-de-
pendent induction of the L-PK promoter in the total absence 
of insulin. The difference between the experimental conditions 
is that the L-PK gene is transcribed in fed rats, but not in 
starved rats. Therefore, glucokinase plus glucose could be 
sufficient to maintain active transcription from glucose-re-
sponsive promoters, while insulin could be required to shift 
the system from an inhibited to an activated state. Along the 
same line, Decaux et al. have previously demonstrated that 
induction of the L-PK gene by glucose and insulin was very 
slow when hepatocytes were isolated from starved rats or 
cultured for a long time without glucose and insulin, and 
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Fig. 2. A : Effect of cAMP analogs on L-PK promoter activity. The 
(L4L3)—119 PK/CAT construct was either transfected alone (black 
bars), or cotransfected with the glucokinase expression vector (gray 
bars) or the control expression vector (open bars). Hepatocytes were 
cultured in the presence of 25 mM glucose and 0.2 nM insulin, with 
or without 0.5 mM 8-bromo-cAMP and 0.1 mM 8,4-chlorophen-
ylthio-cAMP. Each value is the mean of four experiments; vertical 
bars indicate S.E.M. B: Effect of the cotransfection of a catalytic 
PKA ß subunit expression vector on the (L4L3)—119 PK/CAT con-
struct expression. The (L4L3)—119 PK/CAT constuct was cotrans-
fected with increasing amonts of either the PKA ß subunit expres-
sion vector (dark squares), or the mutant inactive ß subunit 
expression vector (open squares). Hepatocytes were cultured in the 
presence of 25 mM glucose and 20 nM insulin. Results are ex-
pressed as a percentage of the CAT activity found with the reporter 
construct transfected alone. Each value is the mean of two to five 
experiments. 
rapid when hepatocytes actively transcribing the L-PK gene 
were depleted of glucose and insulin for 24 h, then restimu-
lated by these agents [11]. 
It is well known that, in vivo, L-PK gene transcription is 
inhibited by glucagon within minutes, and that this inhibitory 
effect can be entirely reproduced by non-hydrolyzable cAMP 
analogs such as 8-bromo-cAMP [16]. Furthermore, we tested 
whether this inhibition of the L-PK promoter activity could 
be reproduced by catalytic subunits of the cAMP-dependent 
protein kinase (PKA). Fig. 2B presents the activity of the 
(L4L3)—119 PK/CAT construct in hepatocytes cultured under 
glucose-insulin conditions and cotransfected with different 
amounts of expression vectors for either the Chinese hamster 
PKA ß catalytic subunit, or the same ß catalytic subunit in-
activated by a mutation within its ATP binding site [10]. Ex-
pression of the PKA ß catalytic subunit in hepatocytes results 
in a strong inhibition of the reporter construct activity, up to 
500 ng. Higher amounts led to non-specific inhibition by 
'squelching'. Therefore, not surprisingly, the negative tran-
scriptional action of cAMP on glucose-dependent activation 
of the L-K promoter is most likely mediated by PKA. 
3.2. cAMP inhibits glucose-dependent activation of the 
L-PK promoter in hepatocytes constitutively synthesizing 
glucokinase 
We then tested the sensitivity of this additional effect of 
insulin to cAMP agonists. Fig. 2A shows that cAMP blocks 
activation of the L-PK promoter in hepatocytes cotransfected 
with the glucokinase vector and cultured in the presence of 
glucose and 0.2 nM insulin. Therefore, the action of cAMP in 
transcriptionally inhibiting the L-PK gene is independent of 
its recognized negative action on transcription of the endoge-
nous glucokinase gene [14]. 
Fig. 3. A: Effect of cAMP competitive antagonists on (L4L3)—119 
PK/CAT construct expression. The reporter construct was tranfected 
either alone, or with the glucokinase expression vector or the con-
trol expression vector. Transfected hepatocytes were cultured with 
0.2 nM insulin as a positive control, or with two different concen-
trations of (Rp)-cAMP(s) (Biolog). Each value is the mean of three 
experiments. B: Effect of cAMP competitive antagonists on the 
PEPCK mRNA accumulation induced by glucagon in hepatocytes 
in primary culture. Hepatocytes were either cultured in 1 uM gluca-
gon, or preincubated for 30 min with different concentrations of 
(Rp)-cAMP(s), then cultured in 1 uM glucagon. 30 ug of total 
RNA was loaded in each well. Relative signal intensity is indicated 
here after standardization in relation to the R45 control probe. 
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3.3. Inhibition of the cAMP-activated pathway is not sufficient 
to replace insulin in the activation of the L-PK promoter 
As insulin is known to counteract effects of the cAMP path-
way, by acting at several levels [17-19], we addressed the 
question whether a blockade of the endogenous cAMP path-
way could suppress the insulin requirement in our model, or 
even replace glucose in stimulating L-PK promoter. For this 
purpose, we used an adenosine cyclic 3',5'-phosphorothioate, 
(Rp)-cAMP(s), which acts as a competitive antagonist of 
cAMP on the mammalian PKA [20]. Fig. 3A shows that 
(Rp)-cAMP(s) at 25 or 50 u\M could not replace a low con-
centration of insulin in allowing L-PK promoter activation by 
glucose and glucokinase. Higher concentrations of (Rp)-
cAMP(s) induced significant cell death, and therefore could 
not be used. Nevertheless, efficacy of (Rp)-cAMP(s) at a 50 
uM concentration was verified by Northern blot experiments, 
showing a strong inhibition of the phosphoenolpyruvate car-
boxykinase mRNA accumulation in hepatocytes cultured in 
the presence of glucagon (Fig. 3B). Such an inhibitory effect 
on cAMP-dependent transcriptional activation confirms re-
sults previously described for the tyrosine aminotransferase 
gene in hepatocytes in primary culture [21]. 
This result indicates that, despite the presence of active 
glucokinase, a blockade of the cAMP pathway is not sufficient 
by itself to allow activation of the L-PK gene promoter, and 
suggests therefore that insulin should exert at least one more 
positive action to allow the glucose signal to be transmitted to 
the transcriptional machinery. 
As a first hypothesis, insulin might remain necessary to 
induce expression of, or to activate, other enzymes involved 
in glucose metabolism. Insulin is known to be involved in the 
short-term and long-term regulation of several other enzymes 
of the glycolytic pathway [22], and, in the pentose phosphate 
pathway, is involved in the transcriptional activation of the 
key enzyme glucose 6-phosphate dehydrogenase [23,24]. A 
puzzling element, however, is the low concentration of insulin 
(0.2 nM) sufficient to achieve expression of the L-PK gene 
when active glucokinase is already present. This extremely 
low concentration is not consistent with an action of insulin 
upon enzymes of the glucose metabolism, since insulin con-
centrations required to activate these enzymes are usually 
much higher, especially in hepatocytes in primary cultures. 
Alternatively, insulin might initiate a phosphorylation-de-
phosphorylation cascade, leading to a modification of the 
phosphorylation status permissive for the glucose-dependent 
activation of the L-PK promoter. One can speculate that 
upon prolonged arrest of transcription of the L-PK gene, 
PKA-dependent or -independent processes might affect either 
directly or indirectly the transcription factors and other pro-
teins constituting the glucose response complex. As a logical 
consequence, a reverse dephosphorylation process should be 
necessary to allow transcriptional activation. The steps where 
insulin could interfere along the glucose signal pathway are 
now under investigation in our laboratory. For this purpose, 
starved rat hepatocytes in primary culture transfected with a 
glucokinase constitutive expression vector provide an attrac-
tive, physiologically relevant model, which will allow us to test 
the capacity of candidate phosphatases or enzymes, synthe-
sized under direction of cotransfected expression vectors, to 
make insulin totally dispensable for the activation of the L-
PK promoter. 
In conclusion, we establish in this paper that both insulin 
and cAMP act on the transcription of the L-PK gene at differ-
ent levels. The first is positive and negative regulation of the 
endogenous glucokinase gene transcription, required to phos-
phorylate glucose to glucose 6-phosphate. In addition, one or 
more downstream steps require low concentrations of insulin 
to allow glucose activation of the L-PK promoter when tran-
scription has been blocked for a long time. 
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